🌎 Chord Energy Initiated, RXO Downgraded, MP Materials Initiated and more...

Ratings changes for Five Below, Establishment Labs, SkyWest, Conformis, Chord Energy, Braze, Five Below and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe.

VIEW MY PORTFOLIO

August 31st, 2023

We MUST back Elon Musk in his fight against… (ad) Porter Stansberry warned of the 1998 banking crisis, the Dot Com blow up, and the 2008 financial collapse… Today, he's issuing a different kind of warning. Full details here. Today's Top Stories 3 Takeaways from the August Inflation Report  The average long-term US mortgage rate fell to 7.18% this week, easing from more than 20-year high URGENT WARNING About United States Bank Accounts (Investor Place Media) On Fire: 5 Best Artificial Intelligence Penny Stocks India shows an impressive 7.8% economic growth in April-June quarter 6 Cybersecurity Stocks: Which is the Best to Buy? UBS reports huge 2Q profit skewed by Credit Suisse takeover and foresees $10B in cost cuts 40 for 40 Playing These 9 "Magic" Stocks (Oxford Club) Oracle Corp.'s 100% Rally: Refueled Stock market today: Wall Street wavers on its way to a loss in August 3 Low P/E Stock ETFs for Hungry Value Investors How major US stock indexes fared Wednesday, 8/30/2023 Quick Links MarketBeat All Access My MarketBeat Account Settings Mobile App Analyst Ratings Company Profiles Dividend Declarations Earnings Announcements Headlines Insider Trades Insider Buying Stocks Insider Selling Stocks Get Five Stocks Free Save $300.00 on Your MarketBeat All Access Subscription (Just $99.00!) (ad) Feel like you're always falling behind the market? Get access to professional investing tools for less than the cost of a Netflix subscription. Upgrade to MarketBeat All Access today for just $99.00 (normally $399.00). Get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports, and much more. Claim Your $300 Discount to MarketBeat All Access Your Watchlist You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. Analysts' Upgrades Arista Networks (NYSE:ANET) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $220.00 price target on the stock, up previously from $177.00. This represents a 13.2% upside from the current price of $194.31. Grupo Aeroportuario del Sureste, S. A. B. de C. V. (NYSE:ASR) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.The current price is $278.92. Ørsted A/S (OTCMKTS:DNNGY) was upgraded by analysts at DNB Markets from a "sell" rating to a "hold" rating.The current price is $20.55. Organization of Football Prognostics (OTCMKTS:GOFPY) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. Guidewire Software (NYSE:GWRE) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $85.00 price target on the stock, up previously from $65.00. This represents a 1.7% downside from the current price of $86.48. Haidilao International (OTCMKTS:HDALF) was upgraded by analysts at Nomura from a "neutral" rating to a "buy" rating.The current price is $3.00. Atlas Arteria (OTCMKTS:MAQAF) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating.The current price is $3.88. Mesoblast (NASDAQ:MESO) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating.The current price is $1.61. 3M (NYSE:MMM) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $113.00 price target on the stock, up previously from $102.00. This represents a 5.8% upside from the current price of $106.83. Mitsubishi (OTCMKTS:MSBHY) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. Grupo Aeroportuario del Centro Norte (NASDAQ:OMAB) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating.The current price is $94.30. Oshkosh (NYSE:OSK) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $115.00 price target on the stock. This represents a 10.7% upside from the current price of $103.89. Shopify (NYSE:SHOP) (TSE:SHOP) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $70.00 price target on the stock, up previously from $60.00. This represents a 6.7% upside from the current price of $65.62. Shopify (NYSE:SHOP) (TSE:SHOP) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $70.00 price target on the stock, up previously from $60.00. This represents a 6.7% upside from the current price of $65.62. SkyWest (NASDAQ:SKYW) was upgraded by analysts at Raymond James from a "market perform" rating to an "outperform" rating. They now have a $55.00 price target on the stock. This represents a 23.9% upside from the current price of $44.38. The Hanover Insurance Group (NYSE:THG) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $126.00 price target on the stock, up previously from $125.00. This represents a 17.5% upside from the current price of $107.19. Vasta Platform (NASDAQ:VSTA) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $5.50 price target on the stock. This represents a 48.2% upside from the current price of $3.71. Exxon Mobil (NYSE:XOM) was upgraded by analysts at Redburn Partners from a "sell" rating to a "neutral" rating. They now have a $105.00 price target on the stock, up previously from $100.00. This represents a 5.6% downside from the current price of $111.22. View today's most recent analysts' upgrades at MarketBeat.com First, the War in Ukraine. Now This?! (ad) The events of 2022-2024 may make or break the dreams of millions of people. But for investors who understand how these events will unfold, it will be possible for them to ride this wave of mayhem successfully … If you have any money in the stock market … Read this urgent warning immediately Analysts' Downgrades Dollar General (NYSE:DG) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $137.29. Dollar General (NYSE:DG) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $132.00 price target on the stock, down previously from $210.00. This represents a 3.9% downside from the current price of $137.29. Ørsted A/S (OTCMKTS:DNNGY) was downgraded by analysts at Nordea Equity Research from a "buy" rating to a "hold" rating.The current price is $20.55. Ørsted A/S (OTCMKTS:DNNGY) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating.The current price is $20.55. Eguana Technologies (OTCMKTS:EGTYF) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.The current price is $0.04. Ero Copper (NYSE:ERO) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating.The current price is $20.81. Gaotu Techedu (NYSE:GOTU) was downgraded by analysts at CLSA from an "outperform" rating to an "underperform" rating. They now have a $3.30 price target on the stock, down previously from $3.32. This represents a 15.4% upside from the current price of $2.86. MasterCraft Boat (NASDAQ:MCFT) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $23.00 price target on the stock, down previously from $37.00. This represents a 7.2% upside from the current price of $21.45. Medical Properties Trust (NYSE:MPW) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $18.00. This represents a 23.8% upside from the current price of $7.27. Outlook Therapeutics (NASDAQ:OTLK) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $1.00 price target on the stock, down previously from $5.00. This represents a 325.4% upside from the current price of $0.24. Outlook Therapeutics (NASDAQ:OTLK) was downgraded by analysts at Chardan Capital from a "buy" rating to a "neutral" rating.The current price is $0.24. Palantir Technologies (NYSE:PLTR) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $9.00 price target on the stock, up previously from $8.00. This represents a 39.8% downside from the current price of $14.94. Roche (OTCMKTS:RHHBY) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating.The current price is $37.30. Hostess Brands (NASDAQ:TWNK) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $28.00 price target on the stock. This represents a 2.0% downside from the current price of $28.56. Victoria's Secret & Co. (NYSE:VSCO) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $18.00 price target on the stock, down previously from $34.00. This represents a 6.4% downside from the current price of $19.24. View today's most recent analysts' downgrades at MarketBeat.com 5 Best AI stocks to invest in 2023 (ad) Investors are getting very rich in AI stocks right now. To get these 5 names and tickers for yourself, click here. Analysts' New Coverage ams-OSRAM (OTCMKTS:AUKUF) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock.The current price is $7.00. Alteryx (NYSE:AYX) is now covered by analysts at William Blair. They set a "market perform" rating on the stock.The current price is $29.52. Chord Energy (NASDAQ:CHRD) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $185.00 price target on the stock. This represents a 15.1% upside from the current price of $160.70. Civitas Resources (NYSE:CIVI) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $95.00 price target on the stock. This represents a 16.9% upside from the current price of $81.28. Establishment Labs (NASDAQ:ESTA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $75.00 price target on the stock. This represents a 25.6% upside from the current price of $59.69. FB Financial (NYSE:FBK) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.The current price is $30.30. Flushing Financial (NASDAQ:FFIC) is now covered by analysts at Raymond James. They set an "outperform" rating and a $17.00 price target on the stock. This represents a 19.9% upside from the current price of $14.18. Lyra Therapeutics (NASDAQ:LYRA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $12.00 price target on the stock. This represents a 243.8% upside from the current price of $3.49. Middlefield Banc (NASDAQ:MBCN) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.The current price is $26.85. MoonLake Immunotherapeutics (NASDAQ:MLTX) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $76.00 price target on the stock. This represents a 35.5% upside from the current price of $56.07. MP Materials (NYSE:MP) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $27.00 price target on the stock. This represents a 28.1% upside from the current price of $21.08. Microvast (NASDAQ:MVST) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $8.00 price target on the stock. This represents a 261.2% upside from the current price of $2.22. Plumas Bancorp (NASDAQ:PLBC) is now covered by analysts at Raymond James. They set an "outperform" rating and a $38.00 price target on the stock. This represents a 6.4% upside from the current price of $35.71. RadNet (NASDAQ:RDNT) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $40.00 price target on the stock. This represents a 21.3% upside from the current price of $32.98. Nykode Therapeutics AS (OTCMKTS:VACBF) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.The current price is $2.36. View today's most recent analysts' new coverage at MarketBeat.com Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Economic Reports Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Unusual Options Volume Unusual Trading Volume Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist. VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. JOIN NOW

Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2023 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.   Today's Bonus Content: The single greatest medical breakthrough of all time?